"Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction"
As a newcomer to the weight loss drug scene, its notable because it can assist individuals in shedding up to 29% of their body weight
Diabetes Care, 42(12), 22722281
In case further glycemic control is still needed, the dose can be augmented to 1.8 mg daily
P.KanekoS.LeeC
While studies and assessments of GLP-1 AOMs, such as the cost-effectiveness study by the Institute for Clinical and Economic Review (ICER), 24 emphasize the potential for improved outcomes in obesity-related chronic diseases (e.g., heart disease, diabetes, osteoarthritis) and the potential related savings, the cost of AOMs must be paid up front, often exceeding the political or financial capacity of state legislatures to fund the program adequately